Intellia Therapeutics (NTLA) Return on Capital Employed Growth (3y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -494.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -649.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 4,853.00 |
| 10 | Intellia Therapeutics | 1.63 Bn | 1.63 Bn | - | -2,692.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2,692.00 |
| Dec 31, 2025 | -1,758.00 |
| Sep 30, 2025 | -1,416.00 |
| Jun 30, 2025 | -2,221.00 |
| Mar 31, 2025 | -2,286.00 |
| Dec 31, 2024 | -2,734.00 |
| Sep 30, 2024 | -2,457.00 |
| Jun 30, 2024 | -1,681.00 |
| Mar 31, 2024 | -2,017.00 |
| Dec 31, 2023 | -1,739.00 |
| Sep 30, 2023 | -1,116.00 |
| Jun 30, 2023 | -93.00 |
| Mar 31, 2023 | 879.00 |
| Dec 31, 2022 | -407.00 |
| Sep 30, 2022 | -1,315.00 |
| Jun 30, 2022 | -723.00 |
| Mar 31, 2022 | -249.00 |
| Dec 31, 2021 | 841.00 |
| Sep 30, 2021 | 577.00 |
| Jun 30, 2021 | -327.00 |
| Mar 31, 2021 | -49.00 |
| Dec 31, 2020 | -242.00 |
| Sep 30, 2020 | -553.00 |
| Jun 30, 2020 | -1,594.00 |
| Mar 31, 2020 | -2,543.00 |
| Dec 31, 2019 | -2,296.00 |
| Sep 30, 2019 | -2,173.00 |
| Jun 30, 2019 | -1,793.00 |
| Mar 31, 2019 | -223.00 |